First Versions of Generic Zyprexa Approved10/24/11
MONDAY, Oct. 24 (HealthDay News) -- The first generic versions
of Zyprexa (olanzapine) have been approved by the U.S. Food and
Drug Administration to treat schizophrenia or bipolar disorder, the
agency said Monday.
Olanzapine has a boxed label warning that the drug can cause
death among elderly people who have psychosis due to confusion and
memory loss, the FDA said in a news release. Other serious adverse
reactions could include high blood sugar, high cholesterol or
triglycerides, and weight gain.
Schizophrenia is a brain disorder that affects about 1 percent
of Americans, with symptoms including hearing voices, paranoia,
being suspicious and withdrawing from everyday life. Bipolar
disorder, also known as manic-depressive illness, includes symptoms
such as unusual changes in mood, energy and ability to perform
The agency said any generic drugs it approves are clinically
equivalent to the brand-name versions in quality, strength, purity
Approval to produce generic versions of olanzapine were given
to: Dr. Reddy's Laboratories Ltd., Teva Pharmaceuticals USA, Apotex
Inc. and Par Phamaceuticals Inc.
The FDA has more about
Copyright © 2011
. All rights reserved.
Please be aware that this information is provided to supplement the care provided by your physician. It is neither intended nor implied to be a substitute for professional medical advice. CALL YOUR HEALTHCARE PROVIDER IMMEDIATELY IF YOU THINK YOU MAY HAVE A MEDICAL EMERGENCY. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with any questions you may have regarding a medical condition.